• Activity INFORMATION

  Overview

  The Food and Drug Administration approved over 50 new medications in 2023. Participants in this presentation will learn the names, indications, role in therapy, adverse effects and pertinent drug interactions, and important patient counseling points about each medication. Even if all the medications are not relevant for all pharmacy practices, it is important the pharmacists and technicians be aware of new drug developments!
  

  Handouts

  • Slide Document :   24077H01_2pp.pdf Download

  • Slide Document :   24077H01_6pp.pdf Download

  Financial Support By

  PharmCon

• Learning OBJECTIVES

  Pharmacist

  List new drugs approved by the FDA in 2023

  Identify important drug alerts and their relevance released by the FDA in 2023

  Describe the approved indication, role in therapy, common adverse effects and drug interactions of selected new drugs

  Pharmacy Technician

  Describe the approved indication, role in therapy, common adverse effects and drug interactions of selected new drugs

  Identify important drug alerts and their relevance released by the FDA in 2023

  List new drugs approved by the FDA in 2023

  Nurse

  Describe the approved indication, role in therapy, common adverse effects and drug interactions of selected new drugs

  List new drugs approved by the FDA in 2023

  Identify important drug alerts and their relevance released by the FDA in 2023

• Activity ACCREDITATION

  Activity Type

  Knowledge

  CE Broker

  20-1187226

  Universal Activity Number

  Pharmacist 0798-0000-24-077-H01-P
  Pharmacy Technician 0798-0000-24-077-H01-T
  Nurse 0798-0000-24-077-H01-N
  

  PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

  PharmCon is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

  In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.

• Activity INSTRUCTION

  Faculty

  Mary Lynn  McPherson, PharmD, PhD, BCPS, FAAHPM Professor and Executive Director, Advanced Post-Graduate Education in Palliative Care, University of Maryland School of Pharmacy

This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).